ICER’s Value Assessments Inform Pricing Decisions
Although new technologies have brought about novel therapies for previously unaddressed diseases, setting prices for these sometimes life-saving treatments remains [...]
Medicare Price Negotiation Idea Gaining Ground
Allowing Medicare to negotiate drug prices with pharma may soon become policy. A growing number of legislators have publicly expressed [...]
Pharma Overhaul Would Reduce Drug Costs While Supporting Innovation
A recent article discusses the impact of legislation intended to lower drug prices on the pharmaceutical industry, such as price [...]
MedPAC Talks Value-Based Healthcare and International Reference Pricing As Aduhelm Cost Sounds Alarms
The Medicare Payment Advisory Commission (MedPAC) is considering a series of measures that would reduce healthcare costs, including international reference pricing [...]
Podcast on Preparing for Insulin Biosimilar Approval Now Available
AmerisourceBergen has released part two of a podcast detailing how insulin biosimilars will affect pharmacies and patients. “In part two [...]
Part 3 of MHE Interview With Prime Therapeutics CEO and President Now Available
Managed Healthcare Executive recently interviewed Prime Therapeutics CEO and President Ken Paulus. Paulus details the benefits of Prime Therapeutics’ recent [...]
Major Corporations Weigh In As Drug Pricing Debate Continues
Major American corporations are split in half as the drug pricing debate continues. One camp, led by the U.S. Chamber [...]
New Report Estimates 30% in CMS Drug Savings Using Domestic Reference Pricing Model
A new report estimates that Medicare could have seen savings as high as 30% had a domestic reference pricing approach [...]
Prescription Drug Pricing Reform Could Mean Discounts on AAP Drugs Pending Clinical Proof
As multidisciplinary stakeholders consider how to reform the prescription drug pricing structure, one recent proposal is gaining traction. Drugs pushed [...]
Whitepaper on Effectively Preparing for CMS Price Transparency Mandates
A whitepaper on preparing for new Medicare price transparency legislation is now available. Sponsored by Rx Savings Solutions, the whitepaper [...]
Vanderbilt Researcher Discusses the Drug Pricing Controversy in KHN Podcast
In a recent KHN podcast, Dr. Stacie Dusetzina at Vanderbilt University shared her thoughts on the ongoing challenges in reducing [...]
Novo Nordisk Agrees to $100 Million Settlement in Insulin Pricing Suit
Novo Nordisk has agreed to a settlement in the amount of $100 million in an insulin pricing lawsuit led by [...]
Kaiser Family Foundation Executive Discusses Medicare Drug Pricing Legislation
Executive Vice President for Health Policy at the Kaiser Family Foundation Larry Levitt shared his thoughts on the Congressional Budget [...]
Public Health and Pharmacy Professor Reviews Recent Publication on Drug Misuse in Healthcare
University of Arizona Professor and Dean Emeritus at the University of Kansas School of Pharmacy Jack Fincham, PhD discussed a [...]
2021’s PBMI Conference Featured Lively Discussions on Specialty Drug Costs, Data Interoperability, and RWD
The Pharmacy Benefit Management Institute (PBMI) recently held its annual conference. This year, the hybrid format allowed for lively discussions [...]
Biden’s Prescription Drug Price Plan Addresses Innovation and Omits Key Topics
President Biden’s drug pricing plan was published on September 9th. It includes key policy reforms such as allowing Medicare to [...]
On-Demand Webinar on Unmet Need in Oncology Healthcare
BioPlus Specialty Pharmacy is offering an on-demand webinar featuring EVP and Oncology Practice Head at Cello Health BioConsulting Jeff Bockman, Ph.D. [...]
OptumRx Strikes Deal With Point32Health for PBM Solutions
OptumRx has reached an agreement with the parent company of Harvard Pilgrim Health Care and Tufts Health Plan, Point32Health. Pharmacy [...]
What is the Specialty Drug Commercialization Pipeline?
Specialty drugs are high cost pharmaceutical products intended for a small number of patients. The specialty drug commercialization process requires [...]
Biogen CEO Discusses Tumultuous Aduhelm Launch
Biogen CEO Michel Vounatsos recently shared his thoughts regarding the hectic Aduhelm launch at the Morgan Stanley 19th Annual Global [...]
ISPOR Article on Prescription Drug Price Variation in Last Decade
In a recent article published in Value in Health, the authors investigate pharmaceutical drug prices. They note significant variation among payers; [...]
Vesto and Oldham Global Collaborate to Offer Financing for High Cost Therapies
Crypto company Vesto and development company Oldham Global have announced a partnership to provide financing for expensive pharmaceuticals. Payers and [...]
Democrats’ Success in Drug Pricing Legislation Hinges on Select Group of Individuals
Democrats are attempting to lower drug prices through legislation. Ten individuals could determine the initiative’s outcome. “The effort’s success depends [...]
Drug Pricing App GoodRx Announces Revenue of $177 Million in Second Quarter of 2021
GoodRx has announced a 43% revenue increase in its second quarter, leading to $177 million in revenue. Its subscribers hit [...]
Congressional Budget Office’s Updated Model Predicts Impact of Pricing Legislation on Pharma Innovation
The Congressional Budget Office (CBO) released an updated model intended to predict how drug pricing bills, including Medicare negotiation, would [...]